enVVeno Medical Corporation (NVNO)

enVVeno Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.54	1.75	3.62	4.56	54.73	9.33
Short-Term Investments	29.41	41.4	42.79	34.49	-	-
Cash & Short-Term Investments	30.95	43.15	46.41	39.04	54.73	9.33
Cash Growth	-36.02%	-7.02%	18.87%	-28.66%	486.29%	614.07%
Other Current Assets	0.55	0.58	0.51	0.39	0.31	0.23
Total Current Assets	31.5	43.73	46.92	39.44	55.04	9.57
Net Property, Plant & Equipment	0.82	1.19	1.68	2.19	2.61	0.94
Other Long-Term Assets	0.03	0.03	0.03	0.03	0.05	0.03
Total Assets	32.35	44.95	48.64	41.66	57.7	10.54
Accounts Payable	2.11	1.73	1.03	1.22	0.56	1.39
Accrued Expenses	-	-	-	-	0.73	1.17
Short-Term Debt	-	-	-	-	-	0.31
Current Portion of Leases	0.29	0.36	0.34	0.31	0.29	0.31
Total Current Liabilities	2.4	2.1	1.37	1.53	1.58	3.19
Long-Term Leases	0.51	0.7	1.06	1.4	1.72	0.25
Total Long-Term Liabilities	0.51	0.7	1.06	1.4	1.72	0.25
Total Liabilities	2.91	2.8	2.44	2.93	3.3	3.44
Common Stock	-	-	-	-	-	0
Additional Paid-in Capital	197.04	194.01	176.24	145.25	136.26	72.42
Retained Earnings	-167.59	-151.86	-130.04	-106.52	-81.85	-65.32
Shareholders' Equity	29.45	42.16	46.2	38.73	54.4	7.1
Total Liabilities & Equity	32.35	44.95	48.64	41.66	57.7	10.54
Total Debt	0.79	1.06	1.4	1.72	2.01	0.88
Net Cash (Debt)	30.16	42.09	45.01	37.33	52.72	8.45
Net Cash Growth	-28.34%	-6.49%	20.58%	-29.20%	523.64%	1776.16%
Net Cash Per Share	1.49	2.46	3.66	3.32	6.07	6.55
Book Value	29.45	42.16	46.2	38.73	54.4	7.1
Book Value Per Share	1.45	2.46	3.76	3.45	6.27	5.50
Tangible Book Value	29.45	42.16	46.2	38.73	54.4	7.1
Tangible Book Value Per Share	1.45	2.46	3.76	3.45	6.27	5.50

Updated Oct 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q